S1PR2 and acute myeloid leukemia: We have previously demonstrated that SK1 inhibition induced Mcl-1 degradation and cell death in AML cells, and that this could be recapitulated by the S1P2 antagonist JTE-013, implicating the SK1-S1P-S1P2 axis in controlling Mcl-1 protein levels13.